Goldman Sachs’s Omnicell OMCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$11.8M Buy
353,397
+11,651
+3% +$488K ﹤0.01% 2924
2025
Q4
$15.5M Sell
341,746
-30,185
-8% -$1.1M ﹤0.01% 2631
2025
Q3
$11.3M Buy
371,931
+60,260
+19% +$1.85M ﹤0.01% 2835
2025
Q2
$9.16M Buy
311,671
+9,669
+3% +$289K ﹤0.01% 2844
2025
Q1
$10.6M Sell
302,002
-139,680
-32% -$5.54M ﹤0.01% 2647
2024
Q4
$19.7M Buy
441,682
+109,615
+33% +$4.92M ﹤0.01% 2144
2024
Q3
$14.5M Buy
332,067
+69,292
+26% +$2.61M ﹤0.01% 2352
2024
Q2
$7.11M Buy
262,775
+19,861
+8% +$575K ﹤0.01% 2832
2024
Q1
$7.1M Buy
242,914
+91,755
+61% +$2.78M ﹤0.01% 2788
2023
Q4
$5.69M Sell
151,159
-75,397
-33% -$2.77M ﹤0.01% 3045
2023
Q3
$10.2M Sell
226,556
-58,620
-21% -$3.55M ﹤0.01% 2371
2023
Q2
$21M Buy
285,176
+128,259
+82% +$8.65M ﹤0.01% 1806
2023
Q1
$9.21M Sell
156,917
-181,392
-54% -$10M ﹤0.01% 2499
2022
Q4
$17.1M Sell
338,309
-316,316
-48% -$19M ﹤0.01% 2103
2022
Q3
$57M Buy
654,625
+193,705
+42% +$20.3M 0.01% 1022
2022
Q2
$52.4M Buy
460,920
+43,343
+10% +$4.97M 0.01% 1093
2022
Q1
$54.1M Sell
417,577
-199,622
-32% -$28.8M 0.01% 1210
2021
Q4
$111M Buy
617,199
+443,378
+255% +$76.9M 0.02% 742
2021
Q3
$25.8M Buy
173,821
+42,005
+32% +$6.44M 0.01% 1823
2021
Q2
$20M Buy
131,816
+3,146
+2% +$438K ﹤0.01% 2049
2021
Q1
$16.7M Sell
128,670
-3,571
-3% -$458K ﹤0.01% 2083
2020
Q4
$15.9M Sell
132,241
-4,915
-4% -$482K ﹤0.01% 2045
2020
Q3
$10.2M Sell
137,156
-242,673
-64% -$16.8M ﹤0.01% 2296
2020
Q2
$26.8M Sell
379,829
-53,470
-12% -$3.66M 0.01% 1441
2020
Q1
$28.4M Buy
433,299
+48,223
+13% +$3.84M 0.01% 1254
2019
Q4
$31.5M Buy
385,076
+28,750
+8% +$2.21M 0.01% 1494
2019
Q3
$25.8M Buy
356,326
+27,994
+9% +$2.05M 0.01% 1594
2019
Q2
$28.2M Buy
328,332
+99,679
+44% +$8.1M 0.01% 1586
2019
Q1
$18.5M Sell
228,653
-80,989
-26% -$6.06M 0.01% 1944
2018
Q4
$19M Buy
309,642
+112,606
+57% +$7.62M 0.01% 1847
2018
Q3
$14.2M Buy
197,036
+71,704
+57% +$4.52M ﹤0.01% 2180
2018
Q2
$6.57M Sell
125,332
-18,951
-13% -$891K ﹤0.01% 2766
2018
Q1
$6.26M Sell
144,283
-3,267
-2% -$150K ﹤0.01% 2723
2017
Q4
$7.16M Buy
147,550
+35,303
+31% +$1.78M ﹤0.01% 2706
2017
Q3
$5.73M Sell
112,247
-4,332
-4% -$207K ﹤0.01% 3017
2017
Q2
$5.03M Buy
116,579
+27,653
+31% +$1.15M ﹤0.01% 3045
2017
Q1
$3.62M Buy
88,926
+40,240
+83% +$1.48M ﹤0.01% 3206
2016
Q4
$1.65M Sell
48,686
-115,322
-70% -$3.97M ﹤0.01% 4027
2016
Q3
$6.28M Buy
164,008
+154,320
+1,593% +$5.75M ﹤0.01% 2849
2016
Q2
$332K Sell
9,688
-83,540
-90% -$2.61M ﹤0.01% 5249
2016
Q1
$2.6M Buy
93,228
+36,015
+63% +$989K ﹤0.01% 3249
2015
Q4
$1.78M Sell
57,213
-12,256
-18% -$362K ﹤0.01% 3743
2015
Q3
$2.16M Sell
69,469
-819
-1% -$29.3K ﹤0.01% 3705
2015
Q2
$2.65M Buy
70,288
+38,265
+119% +$1.4M ﹤0.01% 3562
2015
Q1
$1.12M Sell
32,023
-3,098
-9% -$102K ﹤0.01% 4342
2014
Q4
$1.16M Sell
35,121
-8,996
-20% -$278K ﹤0.01% 4404
2014
Q3
$1.21M Buy
44,117
+1,073
+2% +$29.4K ﹤0.01% 4423
2014
Q2
$1.24M Sell
43,044
-103,864
-71% -$2.8M ﹤0.01% 4498
2014
Q1
$4.21M Sell
146,908
-19,338
-12% -$529K ﹤0.01% 3215
2013
Q4
$4.24M Buy
166,246
+28,139
+20% +$672K ﹤0.01% 3259
2013
Q3
$3.27M Buy
138,107
+61,085
+79% +$1.36M ﹤0.01% 3402
2013
Q2
$1.58M Buy
+77,022
New +$1.42M ﹤0.01% 3949

Other funds holding OMCL

Goldman Sachs's OMCL Position: Q1 2026 in Review

Goldman Sachs increased its Omnicell (OMCL) stake by 3.4% in Q1 2026, buying an estimated $488K and bringing the position to 353,397 shares worth $11.8M. The position accounts for ﹤0.01% of the portfolio, ranked #2924.

Goldman Sachs first reported a position in OMCL in Q2 2013 and has held it in 52 quarters since. The position peaked at $111M in Q4 2021. 272 funds tracked by Wall St. Rank hold OMCL as of Q1 2026.

  • Goldman Sachs held 353,397 shares of Omnicell worth $11.8M as of Q1 2026.
  • Goldman Sachs bought 11,651 Omnicell shares in Q1 2026, an estimated $488K.
  • Omnicell made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #2924 holding.
  • Goldman Sachs first reported a position in Omnicell in Q2 2013 and has held it in 52 quarters since.
  • Goldman Sachs's Omnicell position peaked at $111M in Q4 2021.
  • 272 funds tracked by Wall St. Rank held Omnicell as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.